Exact Sciences in advanced talks to buy Genomic Health for $2.8 billion: Bloomberg

Business

FILE PHOTO: Exact Sciences Laboratories building is shown in Madison, Wisconsin, U.S., March 28, 2019. REUTERS/Howard Schneider

(Reuters) – Cancer diagnostics company Exact Sciences Corp (EXAS.O) is in advanced negotiations to buy healthcare company Genomic Health Inc (GHDX.O) for about $2.8 billion to strengthen its cancer testing, Bloomberg reported on Saturday.

A deal could be announced as early as next week but the talks could still be delayed or fall apart altogether, according to the report, which cited people familiar with the matter.

Exact Sciences and Genomic Health did not respond immediately to a Reuters request for comment on Saturday.

Reporting by Kanishka Singh in Bengaluru; Editing by Sonya Hepinstall

Products You May Like

Articles You May Like

Scientists researching deadly snakebites make major discovery: ‘It is hoped that this trial marks the beginning of an era’
Middle Grade Books for Pride Month—and More Kid Lit Links
Is Chimney Ready to Be Captain on ‘9-1-1’? Kenneth Choi Weighs In
The Roof Collapsed During A Final Destination Screening, And I Would Have Been Panicking
50 Cent Trolls Elon Musk Over Donald Trump Rift: ‘He Really Don’t Give a F—‘